新規β-ラクタム系抗生物質cefodizimeの体内動態及び中枢移行性に及ぼすbenzylpenicillinの影響

Search this Article

Author

    • 松下, 仁 マツシタ, ヒトシ

Bibliographic Information

Title

新規β-ラクタム系抗生物質cefodizimeの体内動態及び中枢移行性に及ぼすbenzylpenicillinの影響

Author

松下, 仁

Author(Another name)

マツシタ, ヒトシ

University

東京大学

Types of degree

薬学博士

Grant ID

乙第10088号

Degree year

1991-03-08

Note and Description

博士論文

Table of Contents

  1. Table of Contents / (0005.jp2)
  2. General introduction / p1 (0007.jp2)
  3. Reference / p4 (0010.jp2)
  4. [PART1] / (0012.jp2)
  5. Prediction of the Pharmacokinetics of Cefodizime and Cefotetan in Humans from Pharmacokinetic Parameters in Animals / p6 (0012.jp2)
  6. Abstract / p7 (0013.jp2)
  7. Introduction / p8 (0014.jp2)
  8. Materials and Methods / p9 (0015.jp2)
  9. Results / p14 (0020.jp2)
  10. Discussion / p16 (0022.jp2)
  11. References / p18 (0024.jp2)
  12. Tables and Figures / p20 (0026.jp2)
  13. [PART2] / (0038.jp2)
  14. Effect of Benzylpenicillin on the Disposition of Cefodizime in Rats: No Net Effect of Total Clearance due to a Decreased Hepatobiliary Clearance and Increased Renal Clearance / p32 (0038.jp2)
  15. Abstract / p33 (0039.jp2)
  16. Introduction / p34 (0040.jp2)
  17. Materials and Methods / p35 (0041.jp2)
  18. Results / p41 (0047.jp2)
  19. Discussion / p43 (0049.jp2)
  20. References / p47 (0053.jp2)
  21. Tables and Figures / p50 (0056.jp2)
  22. [PART3] / (0066.jp2)
  23. Facilitated Transport of Cefodizime into the Rat Certral Nervous System / p60 (0066.jp2)
  24. Abstract / p61 (0067.jp2)
  25. Introduction / p62 (0068.jp2)
  26. Materials and Methods / p64 (0070.jp2)
  27. Results / p70 (0076.jp2)
  28. Discussion / p73 (0079.jp2)
  29. Supplement / p78 (0084.jp2)
  30. References / p83 (0089.jp2)
  31. Tables and Figures / p87 (0093.jp2)
  32. Conclusion and Perspective / p98 (0104.jp2)
3access

Codes

  • NII Article ID (NAID)
    500000083415
  • NII Author ID (NRID)
    • 8000000083625
  • DOI(NDL)
  • NDLBibID
    • 000000247729
  • Source
    • NDL ONLINE
    • NDL Digital Collections
Page Top